Results 151 to 160 of about 7,583,455 (297)

Warfarin time in therapeutic range of primary healthcare patients in the Western Cape Province, South Africa

British Journal of Clinical Pharmacology, EarlyView.
Introduction Warfarin therapy is the mainstay of anticoagulation treatment in South Africa and requires frequent INR monitoring due to interindividual patient variability. Time in therapeutic range (TTR) reflects the proportion of total treatment time during which INR values are within therapeutic range.
Masudah Paleker, Christopher Kelly, Robin Dyers, Eric Decloedt   +3 more
wiley   +1 more source

Long‐acting cabotegravir and rilpivirine in people with HIV receiving chronic anticoagulation: A real‐world case series

British Journal of Clinical Pharmacology, EarlyView.
Background Long‐acting intramuscular cabotegravir plus rilpivirine (LA‐CAB + RPV) is an effective maintenance antiretroviral regimen for virologically suppressed people with HIV. However, its use in individuals receiving chronic anticoagulation is limited by concerns regarding intramuscular bleeding risk, and real‐world data are scarce.
Montserrat Laguno, Berta Torres, Maria Martínez‐Rebollar, Paula Arreba, Octavi Roman, Roger LLobet, Leire Berrocal, Alberto Foncillas, Júlia Calvo, Abiu Sempere, Ivan Chivite, Elisa de Lazzari, Josep Mallolas, Ana González‐Cordón   +13 more
wiley   +1 more source

IMPACT OF LEFT ATRIAL APPENDAGE OCCLUSION ON LEFT ATRIAL FUNCTION

Journal of the American College of Cardiology, 2017
Venkat Lakshmi Kishan Vuddanda, Mohammad-Ali Jazayeri, Ling Li, Mohit Turagam, Srikanth Yandrapalli, Madhav Lavu, Valay Parikh, Donita Atkins, Madhu Reddy, Dhanunjaya Lakkireddy, Shelby Kutty   +10 more
openaire   +1 more source

Novel stroke risk reduction in atrial fibrillation: left atrial appendage occlusion with a focus on the Watchman closure device

, 2017
Arash Alipour, Lisette I S Wintgens, Martin J Swaans, Jippe C Balt, Benno J W M Rensing, Lucas V A Boersma Department of Cardiology, St. Antonius Hospital, Nieuwegein, the Netherlands Abstract: Atrial fibrillation (AF) remains an
Boersma LVA, Alipour A, Wintgens LIS, Swaans MJ, Rensing BJWM, Balt JC   +5 more
core  

Comparing outcomes using low‐dose apixaban and anti‐Xa monitoring and vitamin K antagonists in patients with renal replacement therapy

British Journal of Clinical Pharmacology, EarlyView.
Background Guidelines recommend oral anticoagulation for stroke prevention in atrial fibrillation and secondary prevention of venous thromboembolism. Outside the United States, apixaban is unlicensed for use in patients with end‐stage renal disease (ESRD) receiving renal replacement therapy (RRT).
John K. Bartoli‐Abdou, Alexander T. Cohen, Lucy Vernon, Victoria Collings, Ubonphan Chaichana, Natasha Moore, Hamda Jibril, Li Wei, Nicola Kumar, Karen A. Breen, Andrew J. Doyle   +10 more
wiley   +1 more source

Comparative treatment effects of direct oral anticoagulants versus warfarin for nonvalvular atrial fibrillation in clinical practice vary over time due to channelling

British Journal of Clinical Pharmacology, EarlyView.
Aim Temporal shifts in patient characteristics can influence comparative treatment effects within a certain indication. We investigated patient characteristics and comparative effectiveness and safety for direct oral anticoagulants (DOACs) and warfarin over the time period where DOACs replaced warfarin as preferred stroke prophylaxis in patients with ...
Raoul B. L. J. van den Hemel, Aernoud T. L. Fiolet, Magdalena A. Gamba, Patrick C. Souverein, Olaf H. Klungel, Lourens T. Bloem, Sophie H. Bots   +6 more
wiley   +1 more source

Differential in inter-atrial dyssynchrony and atrial mechanical function in sick sinus syndrome with or without paroxysmal atrial fibrillation

, 2007
Objectives: To investigate the intra- and inter-atrial dyssynchrony in pts with sick sinus syndrome (SSS) combined with paroxysmal atrial fibrillation (PAF).
Wang, MM, Tse, HF, Lau, CP, Lee, KLF, Siu, DCW, Zhang, X   +5 more
core  

Multiple 4q25 risk variants impair calcium homeostasis and compromise left atrial function. [PDF]

Cardiovasc Res
Jiménez-Sábado V, Tarifa C, Vad OB, Casabella-Ramón S, Manzano-Reche G, Lozano-Velasco E, Aceituno C, Caño-Carrillo S, Domínguez JN, Paludan-Müller C, Andreasen L, Montiel J, Guerra JM, Franco D, Svendsen JH, Rodriguez-Font E, Ginel A, Olesen MS, Hove-Madsen L.   +18 more
europepmc   +1 more source

Beyond wound sealing: A dual‐functional adhesive nanofiber membrane promoting coagulation and osteogenesis in extraction sites

BMEMat, EarlyView.
Inspired by the suction mechanics of octopus suckers, a dual‐layer nanofiber membrane integrates antibacterial protection, strong wet adhesion, and osteogenic support, offering a bioinspired strategy for effective hemostasis and alveolar bone preservation.
Huijing Ma, Liheng Gao, Hao Liang, Wentao Jiang, Junyi Wang, Jiajia Wang, Shuhan Duan, Lingxi Meng, Adilijiang Yimiti, Wenjie Zhang   +9 more
wiley   +1 more source

Longitudinal changes in left atrial function during chronic ibrutinib therapy: a prospective observational study. [PDF]

Front Cardiovasc Med
Kolacevic Zeljkovic M, Basic-Kinda S, Čaržavec D, Vodanovic M, Mandac Smoljanovic I, Jaksic O, Novak M, Ostojic-Kolonic S, Dujmovic D, Pejsa V, Aurer I, Bulj N.   +11 more
europepmc   +1 more source